Lorus currently has three products in human clinical trials
with a pipeline of eight clinical trials
in phase II clinical trial
programs and one phase III registration clinical trial
Of those that do make it into human clinical trials
, only one out of five drugs actually reaches the market, and of those, generally only about 30 percent ever recoup their development costs.
The key element in any clinical trial
is the volunteer - the person with MS who consents to the risk and pledges the time.
(complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Acurian's investigator database, which is the largest in the industry, includes professional credentials, clinical trial
experience, location, performance metrics, disease specialties and patient demographics, in addition to numerous other data points.
For example, in the one clinical trial
from South Africa that did report a treatment advantage of ABMT in patients at high risk for metastatic breast cancer, the ABMT arm included drugs not typically used in this country.
Payer funding advocates point out that although elements of the trial may be considered investigational, the majority of the care rendered in a clinical trial
is basic (and high quality) patient care, such that using clinical trial
participation is an arbitrary and artificial distinction.
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials
Review, Q1, 2011
The clinical trial
process: technology in clinical trials
GTx is developing ACAPODENE[R] (toremifene citrate), a selective estrogen receptor modulator, or SERM, in two separate clinical programs in men: first, a pivotal Phase III clinical trial
for the treatment of serious side effects of androgen deprivation therapy for advanced prostate cancer, and second, a pivotal Phase III clinical trial
for the prevention of prostate cancer in high risk men with high grade prostatic intraepithelial neoplasia, or PIN.
NASDAQ:GTXI), the Men's Health Biotech Company, today announced that a per protocol interim safety review by an independent Data Safety Monitoring Board (DSMB) recommended that GTx continue clinical development as planned with its two pivotal Phase III clinical trials
of ACAPODENE[R] (toremifene citrate).
In October 2006, XenoPort announced the completion of enrollment of a 12-week Phase 3 clinical trial
NASDAQ:SOMX) today announced positive results from the company's Phase 3 clinical trial
evaluating SILENOR[TM] (doxepin HCl) in elderly patients with chronic primary insomnia.
The Phase III, double-blind, placebo-controlled clinical trial
was designed by the Steering Committee of the COPD CRN.
NASDAQ: SOMX) today announced results from the company's Phase 2/3 clinical trial
evaluating 20 mg and 40 mg of oral nalmefene hydrochloride, an opiate antagonist, in patients with a diagnosis of pathological gambling.